Virginia Society of Health-System Pharmacists

Latest News and News Archives

<< First  < Prev   1   2   3   4   5   ...   Next >  Last >> 
  • 06/01/2025 5:01 AM | Steve Glass (Administrator)

    VSHP Webinar 

    Wednesday, June 25, 2025 12:00pm-1:00 pm

    Metabolic Dysfunction Associated Steatotic Liver Disease in Patients with Diabetes

    Speaker:

    Keerthana Akkisetty, Pharm.D.
    PGY2 Ambulatory Care Resident
    VCU School of Pharmacy

    Objectives for Pharmacists            

    At the completion of this activity, the participant will be able to:

    1. Discuss updated terminology for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)


    2. Apply screening and diagnosis tools for progression of MASLD


    3. Recognize initiation and monitoring parameters for  pharmacotherapy in a person with MASLD

    Objectives for Pharmacy Technicians      

    At the completion of this activity, the participant will be able to:

    1. Discuss updated terminology for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

    2. List screening and diagnosis tools for progression of MASLD

    Accreditation:

    Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education and has assigned 1 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.  Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit submitted to CPE Monitor as early as 1 day after the event and no later than 60 days after the event.  Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. Participants must participate in the activity and complete the course evaluation in its entirety to claim continuing pharmacy education credit. 

    ACPE UAN:  0108-0000-25-058-L01-P; 0108-0000-25-058-L01-T

    Activity type: Knowledge-based

    This is a member service of VSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

    Non-members will be charged $20.

    To register: https://us06web.zoom.us/webinar/register/WN_I1BD-HBITxC90sFTzxZPLw


  • 06/01/2025 4:15 AM | Steve Glass (Administrator)

    VSHP Webinar 

    Thursday, June 19, 2025 12:00pm-1:00 pm

    Stroke of Genius: Navigating the 2024 Guideline Update in Pharmacologic Prevention

    Speaker:

    Taylor Bernas, PharmD

    Pharmacy Resident

    Chesapeake Regional Medical Center

    Objectives for Pharmacists            

    At the completion of this activity, the participant will be able to:

    • Identify key recommendation updates to the 2024 AHA/ASA Primary Prevention of Stroke guidelines.
    • Describe major changes in lifestyle modification advice (diet, exercise, smoking cessation, sleep, etc.) and risk factor screening (e.g., blood pressure, diabetes, cholesterol, social determinants of health) for stroke prevention
    • Identify updates in pharmacologic management for stroke prevention, including use of antihypertensives, statins and newer lipid-lowering agents, diabetes medications (e.g., GLP-1 agonists), and antithrombotic therapy
    • Discuss stroke prevention considerations in special populations, such as women (pregnancy, menopause, etc.) and transgender patients, as introduced in the 2024 guidelines
    • List diabetes medications that now carry guideline-recommended cardiovascular and stroke risk reduction benefits, including GLP-1 receptor agonists

    Objectives for Pharmacy Technicians      

    At the completion of this activity, the participant will be able to:

    • List key recommendation updates to the 2024 AHA/ASA Primary Prevention of Stroke guidelines.
    • Describe major changes in lifestyle modification advice (diet, exercise, smoking cessation, sleep, etc.) and risk factor screening (e.g., blood pressure, diabetes, cholesterol, social determinants of health) for stroke prevention
    • Recite updates in pharmacologic management for stroke prevention, including use of antihypertensives, statins and newer lipid-lowering agents, diabetes medications (e.g., GLP-1 agonists), and antithrombotic therapy
    • Discuss stroke prevention considerations in special populations, such as women (pregnancy, menopause, etc.) and transgender patients, as introduced in the 2024 guidelines
    • List diabetes medications that now carry guideline-recommended cardiovascular and stroke risk reduction benefits, including GLP-1 receptor agonists

    Accreditation:

    Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education and has assigned 1 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.  Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit submitted to CPE Monitor as early as 1 day after the event and no later than 60 days after the event.  Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. Participants must participate in the activity and complete the course evaluation in its entirety to claim continuing pharmacy education credit. 

    ACPE UAN:  0108-0000-25-057-L01-P; 0108-0000-25-057-L01-T

    Activity type: Application-based

    This is a member service of VSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

    Non-members will be charged $20.

    To register: https://us06web.zoom.us/webinar/register/WN_HrRd2yKzRhC57wo06miT0A


  • 05/27/2025 4:00 PM | Steve Glass (Administrator)

    VSHP Webinar 

    Tuesday, June 17, 2025 3:00pm-4:00 pm

    Potentially Inappropriate Medication Use in Older Adults: Beers Criteria Updates

    Speaker:

    Madeline Johnson, Pharm.D.

    PGY1 Pharmacy Resident 

    HCA Healthcare | Chippenham & Johnston-Willis Hospital

    Objectives for Pharmacists            

    At the completion of this activity, the participant will be able to:

    • Identify the purpose of Beers Criteria and the target audiences.
    • Distinguish medication and criteria changes in the 2023 Beers Criteria update.
    • Discuss evidence used to support changes made to recommendations in the 2023 Beers Criteria update.
    • Formulate practical implementations of Beers Criteria recommendations in the clinical practice setting.

    Objectives for Pharmacy Technicians      

    At the completion of this activity, the participant will be able to:

    • List the purpose of Beers Criteria and the target audiences.
    • Recite medication and criteria changes in the 2023 Beers Criteria update.
    • List evidence used to support changes made to recommendations in the 2023 Beers Criteria update.

    Accreditation:

    Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education and has assigned 1 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.  Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit submitted to CPE Monitor as early as 1 day after the event and no later than 60 days after the event.  Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. Participants must participate in the activity and complete the course evaluation in its entirety to claim continuing pharmacy education credit. 

    ACPE UAN:  0108-0000-25-056-L01-P; 0108-0000-25-056-L01-T

    Activity type: Application-based

    This is a member service of VSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

    Non-members will be charged $20.

    To register: https://us06web.zoom.us/webinar/register/WN_cnvBSER2SrSsodYVn0tVNg


  • 05/22/2025 7:47 AM | Steve Glass (Administrator)

    VSHP Board will hold its annual Leadership Retreat June 27-28 at Wintergreen Resort.

    The Board will use the time there conducting strategic planning and setting goals for VSHP's future.

  • 05/22/2025 7:38 AM | Steve Glass (Administrator)

    Ballots for the election of VSHP Officers have been sent to all pharmacist members.   

    Deadline to vote is 6/3/2025


  • 04/29/2025 10:44 AM | Steve Glass (Administrator)

    VSHP Webinar 

    Tuesday, May 27, 2025 12:00pm-1:00 pm

    Dignity in Every Dose: Advocating for Thoughtful Deprescribing in Older Adults with Intellectual and Development Disabilities (IDD)

    Speaker:

    Jennifer Purdy, PharmD, BCGP, BCACP

    Ambulatory Clinical Pharmacist, Geriatric Specialist

    Riverside Health | Martha W. Goodson Center

    Objectives for Pharmacists            

    At the completion of this activity, the participant will be able to:

    • Identify common medication-related risks in older adults with intellectual and developmental disabilities (IDD).
    • Describe person-centered deprescribing principles that support autonomy, dignity, and individualized care in the IDD population.
    • Apply evidence-based strategies and tools to evaluate and reduce potentially inappropriate medications in older adults with IDD.

    Objectives for Pharmacy Technicians      

    At the completion of this activity, the participant will be able to:

    • Identify common medication-related risks in older adults with intellectual and developmental disabilities (IDD).
    • Describe person-centered deprescribing principles that support autonomy, dignity, and individualized care in the IDD population.
    • List evidence-based strategies and tools to evaluate and reduce potentially inappropriate medications in older adults with IDD.

    Accreditation:

    Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education and has assigned 1 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.  Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit submitted to CPE Monitor as early as 1 day after the event and no later than 60 days after the event.  Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. Participants must participate in the activity and complete the course evaluation in its entirety to claim continuing pharmacy education credit. 

    ACPE UAN:  0108-0000-25-053-L01-P; 0108-0000-25-053-L01-T

    Activity type: Application-based

    This is a member service of VSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

    Non-members will be charged $20.

    To register: https://us06web.zoom.us/webinar/register/WN_RtHOKbJDQhmangCXWPcTJg


  • 04/29/2025 10:01 AM | Steve Glass (Administrator)

    VSHP Webinar 

    Thursday, May 8, 2025 12:00pm-1:00 pm

    The Fungus Among Us: Fungal Infections and Antifungal Therapy

    If you missed it you can view the recording:  Webinars and Online CE

    Speaker:

    Olivia M Iannantuono, PharmD

    PGY2 Pharmacy Resident

    Children's Hospital of The King's Daughters

    Objectives for Pharmacists            

    At the completion of this activity, the participant will be able to:

    • Recognize the difference between yeast, molds, and dimorphic fungi
    • Review regional patterns of dimorphic fungi
    • Identify clinical differences between various fungal infections 
    • Discuss antifungal agents and their place in practice

    Objectives for Pharmacy Technicians      

    At the completion of this activity, the participant will be able to:

    • Recite the difference between yeast, molds, and dimorphic fungi
    • Review regional patterns of dimorphic fungi
    • List clinical differences between various fungal infections 
    • List antifungal agents and their place in practice

    Accreditation:

    Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education and has assigned 1 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.  Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit submitted to CPE Monitor as early as 1 day after the event and no later than 60 days after the event.  Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. Participants must participate in the activity and complete the course evaluation in its entirety to claim continuing pharmacy education credit. 

    ACPE UAN:  0108-0000-25-052-L01-P; 0108-0000-25-052-L01-T

    Activity type: Application-based

    This is a member service of VSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

    Non-members will be charged $20.

    To register: https://us06web.zoom.us/webinar/register/WN_wq54SDuST0myfwOY9wUgOg


  • 04/18/2025 8:40 AM | Steve Glass (Administrator)

    VSHP Webinar 

    Thursday, April 24, 2025 12:00pm-1:00 pm

    Mission Impossible: Overcoming New Delhi Metallo-β-Lactamase Infections

    Recording available:  Webinars and Online CE

     

    Speaker:

     

    Sari Cohen, PharmD

    PGY2 Infectious Diseases Pharmacy Resident 

    University of Virginia (UVA) Health

     

    Objectives for Pharmacists            

    At the completion of this activity, the participant will be able to:

    •           Describe the epidemiology and risk factors for New Delhi metallo-β-lactamase (NDM) infections

               Design an appropriate antimicrobial regimen to treat a carbapenem-resistant enterobacterales (CRE) bacteremia when a metallo-β-lactamase is present

               Analyze current literature describing the efficacy of new agents for treating CRE infections when NDM is present

     

    Objectives for Pharmacy Technicians      

    At the completion of this activity, the participant will be able to:

    •           Describe the epidemiology and risk factors for New Delhi metallo-β-lactamase (NDM) infections

              Recite an appropriate antimicrobial regimen to treat a carbapenem-resistant enterobacterales (CRE) bacteremia when a metallo-β-lactamase is present

     

    Accreditation:

    Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education and has assigned 1 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.  Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit submitted to CPE Monitor as early as 1 day after the event and no later than 60 days after the event.  Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. Participants must participate in the activity and complete the course evaluation in its entirety to claim continuing pharmacy education credit. 

    ACPE UAN:  0108-0000-25-051-L01-P; 0108-0000-25-051-L01-T

    Activity type: Application-based

    This is a member service of VSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

    Non-members will be charged $20.

    To register: https://us06web.zoom.us/webinar/register/WN_AF_pgRZaQFSvxdv8VqWv4g


  • 03/07/2025 12:23 PM | Steve Glass (Administrator)

    The 2025 VSHP Committee on Nominations is pursuing members who wish to get or stay active and involved in VSHP. These candidates should exhibit qualities of leadership, vision and professional awareness that will sustain the enterprising and pioneering spirit that has characterized VSHP.

    The offices of President-elect, Treasurer, Board Member at Large, and Technician at Large are included in this election cycle.

     

    Nominees for President-elect, Treasurer, Board Member at Large must be a pharmacist member of VSHP. 

     

    Nominees for Technician Board Member at Large must be a technician member of VSHP.

     

    The term of office for the President-elect will be June 2025-June 2026; President from June 2026-June 2027; Immediate Past-President June 2027-June 2028.

    Treasurer and Board member at large are 2 year terms from June 2025-June 2027.

    Technician Board Member at Large is a one year term from June 2025-June 2026.

    Position descriptions may be found on the VSHP website at: http://www.vshp.org/Governing-documents

     

    Additionally, VSHP is accepting nominations for Regional President-elect for each of the 8 VSHP Regions. (see map).

     

    Region Presidents-elect are 2 year terms from June 2025-June 2026 as president-elect and June 2026-June 2027 as Region president.

     

    All interested VSHP members who would like to self-nominate or nominate a colleague for any VSHP or Regional office are encouraged to do so via email to the VSHP Nominations Chair, c/o Steve Glass, Executive Director (contact@vshp.org) Nominations will be accepted through Friday, April 11, 2025.

     

    Although any member may nominate a pharmacist for VSHP office, VSHP bylaws state that only pharmacist members may vote in the election. 

     

    Candidates for state office will be vetted by the VSHP Nominations Committee and ballots will be administered electronically after nominees have accepted and been verified.

     

     

     
  • 01/10/2025 3:35 PM | Steve Glass (Administrator)

    2025 Spring Seminar Abstract and Poster Submission

    VSHP is hosting a Poster Competition at VSHP Spring Seminar 2025!

    Accepted posters will be displayed at the VSHP 2025 Spring Seminar on April 3-5, 2025 at Kingsmill Resort in Williamsburg, VA

    General Information:

    • The primary author for each pharmacy resident, pharmacy student, and pharmacy technician poster submission will receive free registration for the 2025 VSHP Spring Seminar.
    • All presenters must be registered for the 2025 VSHP Spring Seminar, at minimum for the day of the presentation
    • Only one submission per member is permitted as primary author. A member may be a co-author for multiple abstract and poster submissions.
    • Posters regarding all aspects of pharmacy including clinical, operational, leadership, education and training, and innovative practice topics (and more!) are encouraged! 

    Award Information:

    • Primary author for pharmacist poster category will be eligible to win a recognition certificate from the VSHP Educational Affairs Committee
    • The primary author for one submission in the pharmacy resident, pharmacy student, and pharmacy technician poster categories will be eligible to win a $100 award and a recognition certificate from the VSHP Educational Affairs Committee
    • One recognition certificate will be provided per category.
    • One $100 award will be provided for the student, resident, and technician categories.

    Key Dates:

    • Monday, March 3rd, 2025: Due date for poster abstract only
    • Monday, March 10th, 2025: Primary author will be notified by e-mail of submission acceptance/declination
    • Friday, March 28th, 2025: Due date for accepted posters to email their poster (in PDF format) to contact@vshp.org 
    • Saturday, April 5th, 2025: Author(s) present and available to discuss their posters at the VSHP Fall Seminar. Posters should remain displayed until the last day of the conference.
    • The winning poster(s) will be alerted via direct email to the presenter and will be announced to the VSHP cohort in the VSHP newsletter and social media posts.

    Poster submission link


<< First  < Prev   1   2   3   4   5   ...   Next >  Last >> 

Contacts

contact@vshp.org

tel:  850-728-4474

fax:  678-401-0259

Copyright© 2025, Virginia Society of Health-System Pharmacists. All rights reserved.                                                                                                 

Powered by Wild Apricot Membership Software